Literature DB >> 3883441

Prophylactic administration of indomethacin for irradiation esophagitis.

N Nicolopoulos, A Mantidis, E Stathopoulos, S Papaodysseas, J Kouvaris, H Varveris, C Papavasiliou.   

Abstract

This is a double-blind study in which 14 randomly selected patients treated for lung cancer by irradiation, were receiving indomethacin, while 14 patients treated also by irradiation served as controls. The purpose of the study was to investigate a possible protective effect of the drug in irradiation esophagitis. The esophagus was included in the irradiation field in all patients. Histologic findings of esophagitis were not different in the two groups. However, endoscopic esophagitis and symptomatology were milder in the patients who received indomethacin.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3883441     DOI： 10.1016/s0167-8140(85)80005-0

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  11 in total

Review 1.  [Prevention and therapy of acute radiation-related morbidity of the skin and mucosa. II, Recommendations of the literature].

Authors:  J S Zimmermann; P Niehoff; R Wilhelm; R Schneider; G Kovács; B Kimmig
Journal:  Strahlenther Onkol       Date:  1998-04       Impact factor: 3.621

Review 2.  [The therapeutic management of radiogenic oral mucositis].

Authors:  W Dörr; I Dölling-Jochem; M Baumann; T Herrmann
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

Review 3.  Anti-inflammatory agents in the management of alimentary mucositis.

Authors:  Rajesh V Lalla; Mark M Schubert; Rene-Jean Bensadoun; Dorothy Keefe
Journal:  Support Care Cancer       Date:  2006-03-25       Impact factor: 3.603

Review 4.  Inflammatory mediators in the oesophagus.

Authors:  G P Morgan; J G Williams
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

5.  A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012.

Authors:  Shannon E Fogh; Snehal Deshmukh; Lawrence B Berk; Amylou C Dueck; Kevin Roof; Sherif Yacoub; Thomas Gergel; Kevin Stephans; Andreas Rimner; Albert DeNittis; John Pablo; Justin Rineer; Terence M Williams; Deborah Bruner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-11-23       Impact factor: 7.038

6.  Effects of mediastinal irradiation on oesophageal function.

Authors:  E Yeoh; R H Holloway; A Russo; M Tippett; H Bermingham; B Chatterton; M Horowitz
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

7.  Amphotericin B lozengers: prophylaxis for esophagitis in thoracic radiotherapy: a prospective study.

Authors:  Karl Wurstbauer; Florian Merz; Felix Sedlmayer
Journal:  Strahlenther Onkol       Date:  2009-08-04       Impact factor: 3.621

8.  Morphology and pathology of radiation-induced esophagitis. Double-blind study of naproxen vs placebo for prevention of radiation injury.

Authors:  E E Soffer; F Mitros; J F Doornbos; J Friedland; J Launspach; R W Summers
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

Review 9.  Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven Review.

Authors:  Markus Laube; Torsten Kniess; Jens Pietzsch
Journal:  Antioxidants (Basel)       Date:  2016-04-19

Review 10.  Can Aidi injection alleviate the toxicity and improve the clinical efficacy of radiotherapy in lung cancer?: A meta-analysis of 16 randomized controlled trials following the PRISMA guidelines.

Authors:  Zheng Xiao; Rui Liang; Cheng-Qiong Wang; Shaofeng Xu; Nana Li; Yuejuan He; Fushan Tang; Ling Chen; Hu Ma
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.